Supply-demand imbalances and distressed selling risks for infectious disease-related products
First written in FY2022. 4 of 7 entries say "Restated". Latest entry: FY2025-H1.
Chukyo Iyakuhin moved to the "Worse" side of this theme in 2022, 1 year before the typical company in this theme (2023).
The whole theme swung hardest in 2023: 4 of 14 companies on the "Worse" side.
8 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「During the interim accounting period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes to existing risks, including supply-demand imbalances and distressed selling involving infectious disease-related products. - FY2024MaterialisedAnnual report
「The Consumer Affairs Agency issued a corrective order on 29 January 2024 regarding the Air Mask series under the Act against Unjustifiable Premiums and Misleading Representations. Although sales of the products had already been discontinued, the company will further strengthen its management systems to prevent recurrence. In addition, an extraordinary loss of ¥127 million was incurred as a result of reassessing the value of products, materials and manufacturing equipment related to the Air Mask series.」
The company received a corrective order regarding the Air Mask series and incurred a ¥127 million extraordinary loss following a reassessment of the value of related products, materials and equipment. - FY2024-Q3RestatedAnnual report
「During the cumulative third-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes to existing risks, including supply-demand imbalances and distressed selling involving infectious disease-related products. - FY2024-Q2MaterialisedAnnual report
「Demand for the Air Mask series of disinfecting and deodorizing products increased amid the COVID-19 pandemic and other factors, but prevention awareness changed following the reclassification of COVID-19 as a Class 5 infectious disease. In addition, similar products from other companies were subject to a surcharge payment order by the Consumer Affairs Agency in connection with a corrective order under the Act against Unjustifiable Premiums and Misleading Representations, causing demand in the general market to decline more than expected. Judging that recovery in general-market demand would be difficult amid these changes in the business environment, the company reassessed the value of products, materials and manufacturing equipment related to the Air Mask series and recognized a ¥122 million extraordinary loss.」
The company experienced a decline in demand for infectious disease-related products and changes in the supply-demand environment, and recognized a ¥122 million extraordinary loss following a reassessment of the value of Air Mask-related products, materials and equipment. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes to existing risks, including supply-demand imbalances and distressed selling involving infectious disease-related products. - FY2023-Q2RestatedAnnual report
「During the cumulative second-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes to existing risks, including supply-demand imbalances and distressed selling involving infectious disease-related products. - FY2022MaterialisedAnnual report
「Changes in the social environment during the COVID-19 pandemic caused unexpected shortages and excess inventories, particularly in the markets for disinfecting and deodorizing products and COVID-19 test kits. We have again recognized that our response to supply-demand imbalances and the rebound in demand was inadequate.」
Shortages and excess inventories of infectious disease-related products, supply-demand imbalances and a rebound in demand actually occurred, and the company itself recognizes that its response was inadequate.